Improving care and surveillance of fevers in the DRC
Official title: Aspects Cliniques, Prise en Charge et Surveillance Des Maladies fébriles en RDC
Run by Institute of Tropical Medicine, Belgium · NCT07345286 · Data updated 2026-11-12
This project tracked people with recent fevers at two hospitals in the DRC to see what causes their fevers, how they are treated, and whether biomarkers like CRP relate to outcomes and antibiotic use.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 2 Months and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Institute of Tropical Medicine, Belgium Academic / other |
| Locations | 1 site (Kinshasa) |
| Status | Recruiting |
| Started | January 20, 2025 |
| Main results expected | January 1, 2027 |
| Study ends | January 1, 2027 |
| Registry record updated | January 15, 2026 |
| Trial ID | NCT07345286 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
People (including children older than two months) who present with a measured or recent fever (within 24 hours) to the participating hospitals and can be contacted for follow-up on days 7, 14 and 21 are ideal candidates.
✕Probably not a fit
Infants under two months, patients recently hospitalized for more than 48 hours in the prior 14 days, or those unable to complete follow-up are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This was a prospective observational cohort of patients presenting with recent or ongoing fever at two clinical sites in the Democratic Republic of Congo between 2021 and 2023. Clinical data and laboratory markers, including white blood cell count and C-reactive protein (CRP), were collected at presentation and patients were followed by phone or visit on days 7, 14 and 21. The study recorded diagnoses, clinical course, outcomes and antibiotic prescribing to characterize epidemiology and management patterns. Findings were intended to inform whether biomarkers and guideline tools could help reduce inappropriate antibiotic use in primary-care and emergency settings.
Why it matters
Potential benefit: If successful, the findings could help reduce unnecessary antibiotic use and improve diagnosis and management of febrile illnesses in the DRC using biomarker-informed guidance.
How similar studies have gone: Other observational and interventional studies in low-resource settings have suggested CRP and similar biomarkers can reduce unnecessary antibiotic prescribing, though evidence remains limited in the DRC specifically.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Ongoing fever objectified at presentation, or documented at home or other health center within 24 hours prior to presentation, defined as: axillary or tympanic temperature \> 37.5°C, or oral or rectal temperature \> 38°C. * Opportunity for contact between patient (or designated relative) and study team on days 7, 14 and 21. * Informed consent to participate signed by the patient (adult) or a legally acceptable representative (child or patients whose condition does not allow them to sign informed consent), with the assent of children aged 12 and over, wherever possible. Exclusion Criteria: * Child less than two months old. * Hospitalization of \> 48h in the last 14 days.
Where it's running
-
Centre Hospitalier Universitaire Renaissance
Kinshasa, Democratic Republic of the Congo Recruiting
Study contacts
- Principal investigator: Emmanuel Bottieau, PhD — Itm
- Study coordinator: Emmanuel Bottieau, PhD
- Email: ebottieau@itg.be
- Phone: +3232476450
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
New care guideline for infants 60 days and younger with fever in Sweden
This project will test a new guideline to see if infants 60 days or younger with fever can safely avoid many invasive tests, hospital stays, and broad antibiotics compared with usual care.
-
Predicting airway problems in children with tracheostomies using caregiver and pediatrician reports.
We will see if symptoms reported by caregivers or pediatricians can predict airway complications found during routine surveillance endoscopy in children with tracheostomies.
-
Automatic surveillance system for patients with gastric premalignant lesions
This study is testing whether an automatic monitoring system can help people with gastric premalignant lesions keep up with their check-ups better than manual reminders or no help at all.
-
Predicting Heart Muscle Recovery After CTO Revascularization
This study looks at whether blood tests and stress echo measurements can predict which patients with CTO will regain heart muscle function after a revascularization procedure.
-
Collagen and omega-3 supplements in middle-aged women
This study tests whether taking collagen and omega-3s together improves joint pain, fatigue, sleep, and overall wellbeing in healthy women aged 35–65 compared with a placebo over 8 weeks.
-
Creatine or placebo to test effects on cognition, muscle strength, and body composition in middle-aged women
This study tests whether taking creatine daily for 8 weeks improves thinking, strength, fatigue, and body composition in healthy middle-aged women compared to a placebo.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.